Among characterized forms of liver microsomal cytochromes P450 in rats are four related isozymes (P450f-i) notable for their lack of inducibility. Immunoblot analyses demonstrated that human livers microsomes contained several proteins related to these rat P450s. A human liver P450, termed HLx, was purified and found by immunochemical assays to resemble rat P450g. Analysis of the NH2-terminal amino acid sequence of HLx indicates that it is related to rat P450s f-i and human liver P45OMP. A monoclonal antibody was used to measure the amounts of HLx in 21 human liver specimens. No correlation between the levels of HLx protein in these specimens and the patients' environmental histories was observed. However, statistical analysis of the data suggests that the distribution of HLx is at least bimodal. We conclude that HLx is a member of a family of human liver P-450s that resembles in its structure, and possibly in its distribution, several liver P450s found in other animals.
Introduction
The cytochromes P-450 in the endoplasmic reticulum of the hepatocyte represent an important biochemical locus for the biotransformation of chemicals. This superfamily of hemoproteins catalyzes the oxidative metabolism of an array of endogenous and exogenous lipophilic compounds (1, 2) . The rates at which these substrates are oxidized and the nature of the metabolites produced depend at least to some extent on the concentrations of individual isozymes of cytochromes P-450. These enzyme concentrations are controlled by genetic factors (3, 4) and also by drugs, diet, and environmental agents (1, 2, 5) that may increase or decrease specific cytochrome P-450 isozymes selectively.
Until recently, the types and amounts of cytochrome P-450 isozymes in the liver could be assessed only indirectly from measurements of the metabolism of prototype substrates in vivo or by liver microsomes. However, advances in protein purification techniques, coupled with immunochemical methods including preparation of monospecific antibodies, has made it possible to purify more than 15 separate polypeptide forms of rat liver cytochrome P-450 (6) and to characterize their structure and regulation (6) (7) (8) . This technology also offers an opportunity to critically assess the question of how relevant the abundant information about animal cytochromes P-450 is to man. For example, we recently demonstrated that human liver contains HLp (9), a cytochrome P-450 that resembles rat liver cytochrome P-450p (10) in its immunochemical characteristics, its NH2-terminal amino acid sequence, its catalytic activities, and its apparent inducibility in man by glucocorticoids or macrolide antibodies (9) . We have also purified from human liver two other novel cytochromes P-450: HLd, a cytochrome orthologous to the 3-methylcholanthrene-inducible P-450d in the rat (11), and HLj, a cytochrome P-450 orthologous to rat cytochrome P-450j in being the major N-nitrosodimethylamine demethylase induced in humans drinking ethanol to excess or receiving isoniazid treatment (12) .
In addition to such inducible forms of liver cytochrome P-450, there is a group of immunochemically related cytochromes in rats (13) (14) (15) (16) and rabbits (17, 18) that comprise the bulk of cytochrome P-450 in untreated animals. It has been suggested that these cytochromes P-450, which are relatively refractory to induction by many xenobiotics, may be involved in pathways for metabolism ofendogenous substrates at steps where modulation by environmental agents would be undesirable (19) . To Purification ofhuman liver cytochrome P-450 HLx. All steps ofthe purification were performed at 4VC unless otherwise noted. Liver microsomes (2 mg/ml of protein in storage buffer [25] ; 1,650 mg of total protein, 880 nmol of cytochrome P-450) prepared from specimen 8 were solubilized by the dropwise addition ofa 20% (wt/vol) solution of cholate (recrystallized two times) to a final concentration of0.6%. The insoluble material was removed by centrifugation at 105,000 g for I h. The resulting supernatant (675 nmol of cytochrome P-450) was divided in half and each portion was applied to one of two identical aminooctylamino-Sepharose 4B columns (2.6 X 37 cm) prepared as previously described (25) Immunoquantitation of the human liver cytochromes P-450 were performed as described in Methods with the densitometric value obtained for specimen 14 arbitrarily set as 100%. * Sources of liver specimens were -patients undergoing hepatic lobectomy (L) or brain-dead renal transplant donors (D). BD, below limit of detection. NA, not available for study. cm]) equilibrated at room temperature with 1 liter of buffer A. The columns were washed with 300 ml of buffer A followed by 500 ml of buffer B (5 mM potassium phosphate, pH 7.7, 0.1 mM EDTA, 20% glycerol, 0.2% Tergitol NP-10, and 0.5% cholate). Then a 600-ml 0-to-250-mM NaCl gradient in buffer B was applied to the column and the first peak fractions containing 417 nm absorbing material were combined. The pooled fractions were dialyzed against I liter ofbuffer C (5 mM potassium phosphate, pH 6.5, 20% glycerol, 0.1 mM EDTA, and 0.2%
Tergitol NP-IO) with three changes over 48 h and then applied at a rate of I ml/min to a CM52 (Whatman Chemical Separations, Inc.) column (1.6 X 30 cm) equilibrated in buffer C. Bound hemoprotein was eluted by application of a 500-ml 0-to-I 50-mM NaCl gradient in buffer C. (26) were transferred to nitrocellulose sheets electrophoretically. The sheets were incubated overnight in phosphate-buffered saline containing 3% bovine serum albumin and 10% calf serum and then were reacted sequentially with murine monoclonal anti-HLx, peroxidase-conjugated rabbit anti-mouse IgG (ICN ImmunoBiologicals, Lisle, IL), and, finally, 3,3'-diaminobenzidine tetrahydrochloride in hydrogen peroxide (0.006%). In the experiments where a rabbit IgG was used as the primary antibody, the second antibody was goat anti-rabbit IgG (ICN) and this was followed by peroxidase rabbit anti-peroxidase (ICN). The density and total area of the stained bands were determined using a scanning densitometer (Carl Zeiss, Inc., Thornwood, NY) (9). In preliminary analyses, dilutions of microsomes isolated from patient 14 produced integrated optical density values directly proportional to the amount of microsomal protein applied to the gel. Noncompetitive ELISA was performed as described (21) with all proteins coated on 96-well microtiter plates at 0.2 Mg/ml. All of the primary antibodies were purified IgG fractions of hyperimmune sera from rabbits except anti-P-450a, which was raised in sheep. The polyclonal antibodies were made monospecific for the antigens ofimmunization by previously reported procedures (21, 27, 28) .
Results and Discussion
We used the approach of sequential column chromatography (Table II) . The 19-amino acid sequence we obtained for HLx revealed no significant homology with that previously determined for several other human cytochromes P-450 including HLp (9), HLd (11), and HLj (12) (Table II) . However, the NH2-terminal amino acid sequence of HLx was homologous in 13 of the identified 18 residues with that reported for an isozyme of human cytochrome P450 identified by its ability to catalyze the metabolism of mephenytoin (P-450MP) (29) (Table II) . Moreover, when compared with rat cytochromes P-450 (6, 14) , HLx shares high homology with the immunochemically related cytochromes P-450f, P-450g, P-450h, and P-450i (14) , all found in untreated animals (Table II) . Consistent with this similarity is the homology at 12 of the 19 identified amino acids between HLx and rabbit P-450 LM 1 (Table II) , a cytochrome that appears to be related to rat cytochrome P-450g (30 
The NH2-terminal amino acid sequence of HLx was determined by automated Edman degradation using a gas-phase sequencer (9) . Yield on the NH2-terminal Met was 76 pmol (15% yield).
cytochrome P-450 antibodies as determined by ELISA and immunoblot analyses. Cytochrome HLx gave a significant positive ELISA reaction with a monospecific polyclonal anti-P-450g IgG that does not react with other rat cytochrome P-450 isozymes (21) ( Table III) . In contrast HLx was not recognized by monospecific antibodies to P-450f, P-450a, P-450b, P-450c, P-450d,or P-450i (Table III) . In addition, none of five monoclonal antibodies specific for cytochrome P-450h (31) gave a significant reaction with HLx in the ELISA (data not shown). Moreover, immunoblots of purified HLx developed with antibody preparations monospecific for cytochrome P-450f, P-450i, or P-450g demonstrated that only the last antibody, anti-P-450g, recognized HLx (Fig. 2 A) . However, immunoblots of HLx developed with polyclonal antibodies directed against cytochrome P-450f, P-450g, or P-450i that had not been absorbed to render them monospecific each reacted strongly with HLx (Fig. 2 B) . These results indicate that HLx is related not only to P-450g but also to P-450f and P-450i. Thus, the results from these immunochemical comparisons indicate that HLx is immunochemically most closely related to P-450g. Next, we examined interindividual differences among 21 human liver specimens for the amounts of HLx protein. We prepared a munne monoclonal antibody against purified HLx for immunoquantitation analyses (Fig. 3 ). This monoclonal antibody gave a negative reaction when tested by immunoblot analysis or ELISA with any of 12 purified rat cytochromes P-450 (P-450a-k and P-450p, data not shown). Analyses of 21 human liver microsomal samples immunoblots developed with monoclonal anti-HLx revealed, in each instance, a single well-defined band having the mobility of HLx (data not shown). We made quantitative measurements of HLx by scanning densitometry of immunoblots developed with the monoclonal anti-HLx IgG (Table I) , the results being expressed relative to the value for patient 14 (arbitrarily set to 100%). There was a 4.7-fold range in the level of liver microsomal immunoreactive HLx (Table I ) among the 21 samples. This range is less than that determined in the same samples for cytochromes HLj (5.9-fold), HLp (7.6-fold), or HLd (25-fold) ( Table I) . The values for the concentration of immunoreactive HLx gave no significant correlation with the age, gender, or history of medications for the patients (Table I) . However, as demonstrated in previous studies, HLj levels were significantly elevated in patients receiving isoniazid or ethanol (12) , and HLp levels were significantly elevated in patients receiving dexamethansone or triacetyloleandomycin (9) . In addition, the widely varying HLd levels did not segregate with any ofthe parameters examined (11). Furthermore, the amounts of HLx immunoreactive protein were unrelated to that for three other human liver cytochromes P-450, HLd (11), HLj (12) , and HLp (9) ( Table I ). eliminate the possibility that the bimodal distribution of HLg levels reflect the influences of yet to be identified environmental factors. It was possible that the function of HLx might resemble that of either rat cytochrome P-450g or rabbit cytochrome P-450 LM 1. For example, LM 1 catalyzes the 2 1-hydroxylation ofprogesterone in rabbits resulting in formation ofdeoxycorticosterone (17) . However, human liver microsomes do not catalyze progesterone hydroxylation at the 21 position (35) . In a reconstituted system consisting ofpurified HLx, optimal phospholipid, and excess purified rat NADPH-cytochrome P-450 reductase, no detectable metabolism of progesterone was observed, including hydroxylation at the 21 position. However, very low but detectable (nmol product/min per nmol HLx) metabolism by HLx was observed with benzo(a)pyrene (0.15), 7-ethoxycoumarin (0.6), and testosterone (0.3, 16a-hydroxytestosterone). In addition, HLx actively metabolized benzphetamine (9.7). Therefore, although HLx is catalytically active, its metabolism of progesterone clearly differs from rabbit LM 1 (17) and rat P-450g (36) . Such a loss of correspondence in substrate specificity of structurally related cytochromes has been noted previously for other interspecies comparisons. For example, cytochrome P-450p metabolizes mephenytoin in the rat (37) , whereas in humans this drug is oxidized not by its *--. 4 -TOP ortholog HLp, but rather by P-450MP, a cytochrome structurally related to but clearly distinct from HLx.
Recently, a full-length complementary DNA (cDNA) clone to a human liver mRNA has been isolated with the use of an antibody probe to rabbit LM 1 (38) . The deduced NH2-terminal amino acid sequence of the protein encoded by this cDNA (38) and that described here for HLx protein (Table II) match each other exactly. Analyses of human genomic DNA with this probe suggest that the encoded protein, probably HLx or a highly related isozyme, is a representative of a large multigene family (Robert H. Tukey, personal communication). This interpretation is supported by our finding multiple protein bands on immunoblots of human liver microsomes developed with antibodies that recognize rat cytochromes P-450f-i (Fig. 2 B) . Based on comparisons of NH2-terminal amino acid sequences (Table II) and complete cDNA sequences (39; Robert H. Tukey, personal communication), we believe that HLx and P-450MP, a human liver mephenytoinmetabolizing isozyme (29) , are structurally related members of the same gene family. A better understanding of the function and genetic control of this family of "uninducible" isozymes may help to explain clinically important interindividual differences in the physiologic and toxicologic processes dependent on the cytochromes P-450.
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